vs
Side-by-side financial comparison of CareTrust REIT, Inc. (CTRE) and 4D Molecular Therapeutics, Inc. (FDMT). Click either name above to swap in a different company.
CareTrust REIT, Inc. is the larger business by last-quarter revenue ($134.9M vs $85.1M, roughly 1.6× 4D Molecular Therapeutics, Inc.). CareTrust REIT, Inc. runs the higher net margin — 82.5% vs 22.8%, a 59.7% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs 55.1%). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs 46.2%).
CareTrust REIT, Inc.CTREEarnings & Financial Report
Target Healthcare REIT is a British property investment company which invests in healthcare properties and holds a large portfolio of care homes. It is structured as a real estate investment trust (REIT) and is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.
4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.
CTRE vs FDMT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $134.9M | $85.1M |
| Net Profit | $111.3M | $19.4M |
| Gross Margin | — | — |
| Operating Margin | — | 17.3% |
| Net Margin | 82.5% | 22.8% |
| Revenue YoY | 55.1% | 8508900.0% |
| Net Profit YoY | 113.5% | 139.1% |
| EPS (diluted) | $0.52 | $0.43 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $134.9M | $85.1M | ||
| Q3 25 | $132.4M | $90.0K | ||
| Q2 25 | $112.5M | $15.0K | ||
| Q1 25 | $96.6M | $14.0K | ||
| Q4 24 | $86.9M | $1.0K | ||
| Q3 24 | $77.4M | $3.0K | ||
| Q2 24 | $68.9M | $5.0K | ||
| Q1 24 | $63.1M | $28.0K |
| Q4 25 | $111.3M | $19.4M | ||
| Q3 25 | $74.9M | $-56.9M | ||
| Q2 25 | $68.5M | $-54.7M | ||
| Q1 25 | $65.8M | $-48.0M | ||
| Q4 24 | $52.1M | — | ||
| Q3 24 | $33.4M | $-43.8M | ||
| Q2 24 | $10.8M | $-35.0M | ||
| Q1 24 | $28.7M | $-32.4M |
| Q4 25 | — | 17.3% | ||
| Q3 25 | 58.1% | -67983.3% | ||
| Q2 25 | 61.3% | -396373.3% | ||
| Q1 25 | — | -383007.1% | ||
| Q4 24 | — | — | ||
| Q3 24 | 43.0% | -1704400.0% | ||
| Q2 24 | 15.1% | -849120.0% | ||
| Q1 24 | — | -136200.0% |
| Q4 25 | 82.5% | 22.8% | ||
| Q3 25 | 56.6% | -63195.6% | ||
| Q2 25 | 60.9% | -364386.7% | ||
| Q1 25 | 68.1% | -342657.1% | ||
| Q4 24 | 60.0% | — | ||
| Q3 24 | 43.2% | -1461433.3% | ||
| Q2 24 | 15.6% | -699060.0% | ||
| Q1 24 | 45.6% | -115717.9% |
| Q4 25 | $0.52 | $0.43 | ||
| Q3 25 | $0.35 | $-1.01 | ||
| Q2 25 | $0.35 | $-0.98 | ||
| Q1 25 | $0.35 | $-0.86 | ||
| Q4 24 | $0.30 | — | ||
| Q3 24 | $0.21 | $-0.79 | ||
| Q2 24 | $0.07 | $-0.63 | ||
| Q1 24 | $0.22 | $-0.66 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $198.0M | $402.7M |
| Total DebtLower is stronger | $894.2M | — |
| Stockholders' EquityBook value | $4.0B | $505.7M |
| Total Assets | $5.1B | $566.7M |
| Debt / EquityLower = less leverage | 0.22× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $198.0M | $402.7M | ||
| Q3 25 | $712.5M | $305.1M | ||
| Q2 25 | $306.1M | $293.2M | ||
| Q1 25 | $26.5M | $321.4M | ||
| Q4 24 | $213.8M | $424.9M | ||
| Q3 24 | $377.1M | $501.9M | ||
| Q2 24 | $495.1M | $541.9M | ||
| Q1 24 | $451.2M | $525.9M |
| Q4 25 | $894.2M | — | ||
| Q3 25 | $893.8M | — | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $822.1M | — | ||
| Q4 24 | $396.9M | — | ||
| Q3 24 | $396.7M | — | ||
| Q2 24 | $671.1M | — | ||
| Q1 24 | $595.9M | — |
| Q4 25 | $4.0B | $505.7M | ||
| Q3 25 | $4.0B | $369.0M | ||
| Q2 25 | $3.3B | $420.9M | ||
| Q1 25 | $2.9B | $469.7M | ||
| Q4 24 | $2.9B | $510.6M | ||
| Q3 24 | $2.4B | $552.9M | ||
| Q2 24 | $1.9B | $588.3M | ||
| Q1 24 | $1.7B | $600.6M |
| Q4 25 | $5.1B | $566.7M | ||
| Q3 25 | $5.1B | $424.0M | ||
| Q2 25 | $4.7B | $473.6M | ||
| Q1 25 | $3.9B | $515.7M | ||
| Q4 24 | $3.4B | $560.4M | ||
| Q3 24 | $2.9B | $604.0M | ||
| Q2 24 | $2.7B | $620.1M | ||
| Q1 24 | $2.3B | $629.9M |
| Q4 25 | 0.22× | — | ||
| Q3 25 | 0.22× | — | ||
| Q2 25 | 0.35× | — | ||
| Q1 25 | 0.28× | — | ||
| Q4 24 | 0.14× | — | ||
| Q3 24 | 0.16× | — | ||
| Q2 24 | 0.35× | — | ||
| Q1 24 | 0.36× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $394.0M | $28.6M |
| Free Cash FlowOCF − Capex | — | $28.5M |
| FCF MarginFCF / Revenue | — | 33.5% |
| Capex IntensityCapex / Revenue | — | 0.1% |
| Cash ConversionOCF / Net Profit | 3.54× | 1.47× |
| TTM Free Cash FlowTrailing 4 quarters | — | $-109.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $394.0M | $28.6M | ||
| Q3 25 | $100.9M | $-46.5M | ||
| Q2 25 | $100.8M | $-43.4M | ||
| Q1 25 | $71.4M | $-47.8M | ||
| Q4 24 | $244.3M | $-134.6M | ||
| Q3 24 | $67.2M | $-29.4M | ||
| Q2 24 | $53.0M | $-30.2M | ||
| Q1 24 | $48.8M | $-29.1M |
| Q4 25 | — | $28.5M | ||
| Q3 25 | — | $-46.6M | ||
| Q2 25 | — | $-43.4M | ||
| Q1 25 | — | $-48.4M | ||
| Q4 24 | — | $-138.4M | ||
| Q3 24 | — | $-31.2M | ||
| Q2 24 | — | $-30.6M | ||
| Q1 24 | — | $-29.8M |
| Q4 25 | — | 33.5% | ||
| Q3 25 | — | -51765.6% | ||
| Q2 25 | — | -289620.0% | ||
| Q1 25 | — | -345635.7% | ||
| Q4 24 | — | -13837100.0% | ||
| Q3 24 | — | -1038966.7% | ||
| Q2 24 | — | -611840.0% | ||
| Q1 24 | — | -106421.4% |
| Q4 25 | — | 0.1% | ||
| Q3 25 | — | 101.1% | ||
| Q2 25 | — | 440.0% | ||
| Q1 25 | — | 4507.1% | ||
| Q4 24 | — | 378600.0% | ||
| Q3 24 | — | 59266.7% | ||
| Q2 24 | — | 6980.0% | ||
| Q1 24 | — | 2535.7% |
| Q4 25 | 3.54× | 1.47× | ||
| Q3 25 | 1.35× | — | ||
| Q2 25 | 1.47× | — | ||
| Q1 25 | 1.08× | — | ||
| Q4 24 | 4.68× | — | ||
| Q3 24 | 2.01× | — | ||
| Q2 24 | 4.92× | — | ||
| Q1 24 | 1.70× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
